These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30367397)

  • 1. Pioglitazone Reduces Hepatocellular Carcinoma Development in Two Rodent Models of Cirrhosis.
    Li S; Ghoshal S; Sojoodi M; Arora G; Masia R; Erstad DJ; Lanuti M; Hoshida Y; Baumert TF; Tanabe KK; Fuchs BC
    J Gastrointest Surg; 2019 Jan; 23(1):101-111. PubMed ID: 30367397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saroglitazar suppresses the hepatocellular carcinoma induced by intraperitoneal injection of diethylnitrosamine in C57BL/6 mice fed on choline deficient, l-amino acid- defined, high-fat diet.
    Giri SR; Bhoi B; Trivedi C; Rath A; Rathod R; Sharma A; Ranvir R; Kadam S; Ingale K; Patel H; Nyska A; Jain MR
    BMC Cancer; 2023 Jan; 23(1):59. PubMed ID: 36650455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma.
    Fuchs BC; Hoshida Y; Fujii T; Wei L; Yamada S; Lauwers GY; McGinn CM; DePeralta DK; Chen X; Kuroda T; Lanuti M; Schmitt AD; Gupta S; Crenshaw A; Onofrio R; Taylor B; Winckler W; Bardeesy N; Caravan P; Golub TR; Tanabe KK
    Hepatology; 2014 Apr; 59(4):1577-90. PubMed ID: 24677197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis.
    Schiffer E; Housset C; Cacheux W; Wendum D; Desbois-Mouthon C; Rey C; Clergue F; Poupon R; Barbu V; Rosmorduc O
    Hepatology; 2005 Feb; 41(2):307-14. PubMed ID: 15660382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration of Steamed and Freeze-Dried Mature Silkworm Larval Powder Prevents Hepatic Fibrosis and Hepatocellular Carcinogenesis by Blocking TGF-β/STAT3 Signaling Cascades in Rats.
    Lee DY; Yun SM; Song MY; Ji SD; Son JG; Kim EH
    Cells; 2020 Feb; 9(3):. PubMed ID: 32121064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asarone and metformin delays experimentally induced hepatocellular carcinoma in diabetic milieu.
    Das BK; Choukimath SM; Gadad PC
    Life Sci; 2019 Aug; 230():10-18. PubMed ID: 31121175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiazolidinediones improve hepatic fibrosis in rats with non-alcoholic steatohepatitis by activating the adenosine monophosphate-activated protein kinase signalling pathway.
    Zhang W; Wu R; Zhang F; Xu Y; Liu B; Yang Y; Zhou H; Wang L; Wan K; Xiao X; Zhang X
    Clin Exp Pharmacol Physiol; 2012 Dec; 39(12):1026-33. PubMed ID: 23127227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a novel mouse model of hepatocellular carcinoma with nonalcoholic steatohepatitis using a high-fat, choline-deficient diet and intraperitoneal injection of diethylnitrosamine.
    Kishida N; Matsuda S; Itano O; Shinoda M; Kitago M; Yagi H; Abe Y; Hibi T; Masugi Y; Aiura K; Sakamoto M; Kitagawa Y
    BMC Gastroenterol; 2016 Jun; 16(1):61. PubMed ID: 27296438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular carcinoma in a mouse model fed a choline-deficient, L-amino acid-defined, high-fat diet.
    Ikawa-Yoshida A; Matsuo S; Kato A; Ohmori Y; Higashida A; Kaneko E; Matsumoto M
    Int J Exp Pathol; 2017 Aug; 98(4):221-233. PubMed ID: 28895242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Branched-chain amino acids ameliorate fibrosis and suppress tumor growth in a rat model of hepatocellular carcinoma with liver cirrhosis.
    Cha JH; Bae SH; Kim HL; Park NR; Choi ES; Jung ES; Choi JY; Yoon SK
    PLoS One; 2013; 8(11):e77899. PubMed ID: 24223741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoprevention of hepatocellular carcinoma. Proof of concept in animal models.
    Borbath I; Stärkel P
    Acta Gastroenterol Belg; 2011 Mar; 74(1):34-44. PubMed ID: 21563652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin prevents hepatocellular carcinoma development by suppressing hepatic progenitor cell activation in a rat model of cirrhosis.
    DePeralta DK; Wei L; Ghoshal S; Schmidt B; Lauwers GY; Lanuti M; Chung RT; Tanabe KK; Fuchs BC
    Cancer; 2016 Apr; 122(8):1216-27. PubMed ID: 26914713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Adenosine Monophosphate (AMP) Analog, 5-Aminoimidazole-4-Carboxamide Ribonucleotide (AICAR) Inhibits Hepatosteatosis and Liver Tumorigenesis in a High-Fat Diet Murine Model Treated with Diethylnitrosamine (DEN).
    Gao J; Xiong R; Xiong D; Zhao W; Zhang S; Yin T; Zhang X; Jiang G; Yin Z
    Med Sci Monit; 2018 Nov; 24():8533-8543. PubMed ID: 30474622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The PPARgamma agonist pioglitazone inhibits early neoplastic occurrence in the rat liver.
    Borbath I; Leclercq I; Moulin P; Sempoux C; Horsmans Y
    Eur J Cancer; 2007 Jul; 43(11):1755-63. PubMed ID: 17582756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma.
    Duan XY; Pan Q; Yan SY; Ding WJ; Fan JG; Qiao L
    BMC Gastroenterol; 2014 Nov; 14():195. PubMed ID: 25410681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic steatohepatitis-associated hepatocarcinogenesis in mice fed a modified choline-deficient, methionine-lowered, L-amino acid-defined diet and the role of signal changes.
    Suzuki-Kemuriyama N; Abe A; Nakane S; Yuki M; Miyajima K; Nakae D
    PLoS One; 2023; 18(8):e0287657. PubMed ID: 37535625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents.
    Moeini A; Torrecilla S; Tovar V; Montironi C; Andreu-Oller C; Peix J; Higuera M; Pfister D; Ramadori P; Pinyol R; Solé M; Heikenwälder M; Friedman SL; Sia D; Llovet JM
    Gastroenterology; 2019 Nov; 157(5):1383-1397.e11. PubMed ID: 31344396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent mTORC1 activation via Depdc5 deletion results in spontaneous hepatocellular carcinoma but does not exacerbate carcinogen- and high-fat diet-induced hepatic carcinogenesis in mice.
    Xu L; Yang C; Wang J; Li Z; Huang R; Ma H; Ma J; Wang Q; Xiong X
    Biochem Biophys Res Commun; 2021 Nov; 578():142-149. PubMed ID: 34562654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer.
    Wei G; An P; Vaid KA; Nasser I; Huang P; Tan L; Zhao S; Schuppan D; Popov YV
    Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G174-G188. PubMed ID: 31630534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standardization of diethylnitrosamine-induced hepatocellular carcinoma rat model with time based molecular assessment.
    Ghufran H; Azam M; Mehmood A; Butt H; Riazuddin S
    Exp Mol Pathol; 2021 Dec; 123():104715. PubMed ID: 34699901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.